BRAIN Biotech AG (ETR:BNN)
Germany · Delayed Price · Currency is EUR 2.510
+0.040 (1.62%)
Apr 24, 2026, 5:35 PM CET
BRAIN Biotech AG Market Cap
BRAIN Biotech AG has a market cap or net worth of €54.84 million as of April 24, 2026. Its market cap has increased by 6.81% in one year.
Market Cap
54.84M
Enterprise Value
49.69M
Revenue
49.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.51
Market Cap Chart
Since February 9, 2016, BRAIN Biotech AG's market cap has decreased from 149.34M to 54.84M, a decrease of -63.28%. That is a compound annual growth rate of -9.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 54.84M | -0.40% |
| Dec 30, 2025 | 55.06M | -29.01% |
| Dec 30, 2024 | 77.56M | -3.01% |
| Dec 29, 2023 | 79.96M | -37.33% |
| Dec 30, 2022 | 127.59M | -37.20% |
| Dec 30, 2021 | 203.18M | 13.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evonik Industries AG | 8.15B |
| Wacker Chemie AG | 4.88B |
| Fuchs SE | 4.54B |
| Verbio SE | 2.39B |
| AlzChem Group AG | 1.86B |
| LANXESS Aktiengesellschaft | 1.61B |
| Uzin Utz SE | 372.27M |
| H&R GmbH & Co. KGaA | 166.01M |